FDA Webview
X

Free FDA Notices

FDA OKs Novartis sNADA for Canine Dental Pain

01/26/2012

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Novartis Animal Health U.S., Inc. supplemental NADA that provides for veterinary prescription use of deracoxib tablets in dogs for the control of postoperative pain and inflammation associated with dental surgery and the addition of a 12-mg size tablet. To view this final rule, click here.

LATEST NEWS